Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company developing novel drugs for cancer, fibrosis and inflammation, announced it has received notice from the...
Inhibrx, Inc., a biotechnology company with four clinical programs in development and a strong emerging pipeline, announced that the European Commission ("EC"), based on...
Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that, in conjunction with its partner...
Infinome Biosciences, a next generation biomanufacturing company, and Kalsec Inc, a leading global producer of natural spice and herb extracts for the food and...
Roche announced US Food and Drug Administration (FDA) approval of a label expansion for the VENTANA MMR RxDx Panel. This approval advances the company's...
